Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Motion Delos: An Open Label Study to Investigate the Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness During Travel

NCT06138613 is registered in ClinicalTrials.gov with Vanda Pharmaceuticals as lead sponsor.

NCT NCT06138613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06138613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Motion Delos: An Open Label Study to Investigate the Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness During Travel
Lead sponsor
Vanda Pharmaceuticals
Phase
Phase 3
Overall status
Active, not recruiting
Start date
February 27, 2023
Completion date
December 30, 2027
Enrollment
705 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

motion sickness